Wuhan YZY Biopharma Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	166.18	126.28	196.68	153.52	83.09
Trading Asset Securities	-	-	-	15	2.5
Cash & Short-Term Investments	166.18	126.28	196.68	168.52	85.59
Cash Growth	2.68%	-35.80%	16.71%	96.90%	-
Accounts Receivable	5	51.11	-	-	-
Other Receivables	8.09	6.83	16.03	0.66	-
Receivables	13.09	57.94	16.03	0.66	-
Inventory	3.68	4.26	5.77	10.62	8.91
Other Current Assets	12.34	32.86	31.62	59.16	31.14
Total Current Assets	195.3	221.34	250.1	238.96	125.64
Property, Plant & Equipment	43.17	45.41	50.38	54.55	59.96
Other Long-Term Assets	1.16	1.09	1.14	9.34	14.55
Total Assets	239.63	267.84	301.62	302.84	200.16
Accounts Payable	0.09	0.14	0.19	0.08	4.85
Accrued Expenses	52.2	45.17	37.95	22.17	16.03
Short-Term Debt	-	-	-	76.5	28
Current Portion of Long-Term Debt	101.77	75.82	89.5	-	-
Current Portion of Leases	0.28	0.36	0.46	0.17	0.4
Current Income Taxes Payable	0.31	0.47	0.5	0.45	0.36
Current Unearned Revenue	14.71	21.08	0.64	3.85	1.45
Other Current Liabilities	43.1	43.1	44.58	43.74	5.82
Total Current Liabilities	212.45	186.14	173.82	146.96	56.91
Long-Term Debt	54.62	51.08	-	-	-
Long-Term Leases	-	0.09	0.15	-	0.08
Total Liabilities	267.07	237.31	173.97	146.96	56.99
Common Stock	193.85	193.85	193.85	182	-
Additional Paid-In Capital	345.01	345.01	345.01	193.38	613.6
Retained Earnings	-569.22	-510.39	-412.79	-221.09	-572.44
Comprehensive Income & Other	2.92	2.06	1.58	1.58	102
Shareholders' Equity	-27.45	30.54	127.65	155.88	143.16
Total Liabilities & Equity	239.63	267.84	301.62	302.84	200.16
Total Debt	156.67	127.35	90.11	76.67	28.48
Net Cash (Debt)	9.52	-1.08	106.57	91.85	57.11
Net Cash Growth	-77.19%	-	16.02%	60.85%	-
Net Cash Per Share	0.05	-0.01	0.58	0.53	0.38
Filing Date Shares Outstanding	193.85	193.85	193.85	182	152.11
Total Common Shares Outstanding	193.85	193.85	193.85	182	152.11
Working Capital	-17.16	35.2	76.28	92	68.73
Book Value Per Share	-0.14	0.16	0.66	0.86	0.94
Tangible Book Value	-27.45	30.54	127.65	155.88	143.16
Tangible Book Value Per Share	-0.14	0.16	0.66	0.86	0.94
Buildings	-	15.4	15.04	15.04	15.04
Machinery	-	68.16	68.33	66.81	65.46
Construction In Progress	-	16.85	16.85	16.85	16.85
Leasehold Improvements	-	1.76	1.76	1.76	1.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.